×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Clinical: A 6-month & 18-month Prospective, Randomized, Placebo-contro
clinical
1,170 words
KG: A 6-month & 18-month Prospective, Randomized, Placebo-controlled, Double-blin... (NCT06709014)
2026-03-28
kind:clinical-trial
section:clinical-trials
state:published
Contents
A 6-month & 18-month Prospective, Randomized, Placebo-controlled, Double-blin... (NCT06709014)
Knowledge Graph
Related Hypotheses (26)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Purinergic Signaling Polarization Control
Score: 0.55
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Optogenetic Control of Mitochondrial Transfer Networks
Score: 0.38
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56
Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.56
Epigenetic Memory Erasure via TET2 Activation
Score: 0.52
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51
Noradrenergic-Tau Propagation Blockade
Score: 0.51
Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.49
Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.48
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47
Arginine Methylation Enhancement Therapy
Score: 0.46
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.44
HSP90-Tau Disaggregation Complex Enhancement
Score: 0.44
Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics
Score: 0.42
Biorhythmic Interference via Controlled Sleep Oscillations
Score: 0.41
Temporal TET2-Mediated Hydroxymethylation Cycling
Score: 0.41
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Partial Neuronal Reprogramming via Modified Yamanaka Cocktai
Score: 0.40
KDM6A-Mediated H3K27me3 Rejuvenation
Score: 0.38
DNMT1-Targeting Antisense Oligonucleotide Reset
Score: 0.36
Synaptic Vesicle Tau Capture Inhibition
Score: 0.34
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.34
Show 21 more
Related Analyses (3)
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Related Experiments (1)
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
See Also (15)
Section 194: Advanced Mitochondrial Dynamics and Biogen
therapeutic · Pages share 5 hypotheses
Mitochondrial Replacement Therapy for Neurodegeneration
therapeutic · Pages share 5 hypotheses
Mitochondrial Biogenesis Inducers in Neurodegeneration
therapeutic · Pages share 5 hypotheses
Neurodegeneration
disease · Pages share 5 hypotheses
A Phase 2 Double-Blind, Randomized, Placebo-Controlled
clinical · Pages share 5 hypotheses
Synaptic Therapy Alzheimer's Research Trial (START): A
clinical · Pages share 5 hypotheses
Optogenetically-Modified Neurons in Neurodegeneration R
cell · Pages share 5 hypotheses
Yoga Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
YAP/TEAD Pathway Modulators for Neurodegeneration
therapeutic · Pages share 4 hypotheses
Wnt Signaling Modulators for Neurodegeneration
therapeutic · Pages share 4 hypotheses
vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 4 hypotheses
Vitamin B Complex Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
VIP/VPAC Receptor Modulators for Neurodegeneration
therapeutic · Pages share 4 hypotheses
Vestibular and Balance Therapy for CBS/PSP
therapeutic · Pages share 4 hypotheses
VEGF and Angiogenesis Therapy
therapeutic · Pages share 4 hypotheses
Show 10 more
Knowledge Graph (1 edges)
A 6-month & 18-month Prospective, Randomized, Placebo-controlled, Double-blin... (NCT06709014)
references
BACE1